To ask Her Majesty's Government, further to the Written Answers by Lord O'Shaughnessy on 8 March (HL5784 to HL5786), whether they propose to have fixed tariff prices for prescribed special medicinal products; and when they will table their proposals for consultation with stakeholders.
Since 2011 for the most commonly prescribed special medicinal products (also known as “specials”) a reimbursement price is listed in the Drug Tariff (i.e. a “fixed Tariff price”). We have continued to expand the number of products for which there is a reimbursement price listed in the Drug Tariff, thus reducing the cost and the variation in what the National Health Service pays. As stated in my earlier response, the Government is considering how to implement its powers in the 2017 Act on the way it reimburses all special medicinal products. Any proposals will be subject to consultation with relevant stakeholders in due course.